Medicare begins to cover ultrasounds to detect aortic aneurysms

Medicare on Jan. 1 began to cover ultrasounds to detect abdominal aortic aneurysms in beneficiaries at high risk for the condition, the Charlotte Observer reports.

Medicare beneficiaries with a family history of AAAs and male beneficiaries older than age 65 who have smoked more than 100 cigarettes in their lifetimes qualify for the ultrasounds. Medicare beneficiaries who qualify for the ultrasounds must receive them within the first six months after they become eligible for the program (Moore, Charlotte Observer, 12/30/06).

Impact

Medicare coverage of ultrasounds to detect AAAs could lead to increased revenue for Medtronic and other medical device companies that market endovascular stent grafts to treat the condition, according to some analysts and vascular physicians (Snowbeck, St. Paul Pioneer Press, 1/4). Medtronic lobbied for the Medicare coverage, a provision included in a budget reconciliation bill that President Bush signed in February 2006 (Charlotte Observer, 12/30/06). Jan Wald, an analyst at A.G. Edwards, said, "Right now, it's probably a $100 million to $150 million market" for endovascular stent grafts. "It could very easily be a $500 million to $800 million market down the road," Wald said, adding, "Given the way the world is going, endovascular procedures (such as the aneurysm repair) and peripheral procedures are getting more important for (Medtronic's) growth" (St. Paul Pioneer Press, 1/4).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vial size could save Medicare millions on Alzheimer's drug